Open on EUR-Lex ↗
◷
New version applies from 23/09/2013. 165 provisions change. Later versions: 25/04/2014, 20/11/2019, 29/03/2021, 10/06/2021, 15/04/2022, 26/05/2024, 11/06/2024, 15/06/2026, 19/08/2026. Recital 12 changes in this version: compare with the current text.

Recital 12

Recital 12

(12)With a view to achieving a high level of protection of human health, animal health and the environment, active substances with the worst hazard profiles should not be approved for use in biocidal products except in specific situations. These should include situations when approval is justified because of the negligible risk from exposure to the substance, human health, animal health or environmental reasons or the disproportionate negative impact for society of non-approval. When deciding if such active substances may be approved, the availability of suitable and sufficient alternative substances or technologies should also be taken into account.

Official text · the act as publishedFrom the act as published (consolidated texts do not carry recitals or the preamble). Open full page ↗
11 queries · page built in 17 msInventory f82bbfa3